Four new D-secopaclitaxel analogues were synthesized from paclitaxel. The k
ey step of the synthesis involved the opening of the D-ring by Jones oxidat
ion. Two of the compounds had been predicted to be nearly as active as pacl
itaxel in a minireceptor model of the binding site on tubulin, but all were
biologically inactive in an in vitro cytotoxic assay and a tubulin assembl
y assay. The biological results identify a weakness in our predictive minir
eceptor model and suggest a corrective remedy in which additional amino aci
ds are needed to accommodate ligand-protein steric effects around the oxeta
ne ring. These changes to-the model lead to correct predictions of the bioa
ctivity. Conformational analysis and dynamics simulations of the compounds
showed that the 4-acetyl substituent is as important as the oxetane in dete
rmining the A ring conformation.